US-based, oncology-focused health technology developer Carevive Systems has completed an $18m series C round led by Philips Health Technology Ventures, an investment vehicle for medical device and electronics group Philips.
The round included pharmaceutical company Debiopharm’s Innovation Fund, health IT equipment producer Cerner, Qure Ventures, HLM Venture Partners, LRVHealth, OurCrowd’s digital health fund and Carevive founder Madelyn Trupkin Herzfeld.
Carevive has created technology that helps physicians remotely monitor the condition of cancer patients and manage their treatment. It secured $15m for the first close of the round in February 2020.
The company had previously received $7.2m in a series B round featuring HLM Venture Partners and LRVHealth (then known as Long River Ventures) in 2016. It has not revealed details of earlier financing.
Bruno Lempernesse, CEO of Carevive since December 2020, said: “The funds will allow Carevive to bring its software and analytics platform, which uniquely connects clinical data with patients’ real-world reported experiences, to even more clinicians, patients, life science companies and payers.”
Pharmaceutical firm Pfizer selected Carevive PROmpt as the first patient-reported outcomes (PRO) challenge winner in November 2020.
